
MLP Sağlık reported stronger-than-expected third-quarter profit, while broker price targets ranged from TRY608 to TRY728.50.
MLP Sağlık reported third-quarter net profit of TRY2.22 billion, above the TRY1.56 billion median estimate from Matriks. Its consolidated net profit for the first nine months of 2026 rose 5.05% year over year to TRY5.55 billion.
After the results, brokerage targets for MPARK ranged from TRY608 at Kuveyt Türk Yatırım to TRY728.50 at Fiba Yatırım. Gedik Yatırım announced a target of TRY723 and an “Outperform” rating; most other listed firms kept their targets unchanged.
As of 08:01 UTC on Nov. 5, MPARK traded at TRY424.25, up 5.01% since the previous close.
This article was produced with the help of AI technology. Based on reporting by the outlets listed above.